{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T05:06:19Z","timestamp":1772168779991,"version":"3.50.1"},"reference-count":23,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns3:p>It is well known that typical antipsychotic drugs have been implicated as a cause of ventricular arrhythmias and cardiac arrest; studies have shown that conventional antipsychotics increase the risk of hospitalization for ventricular arrhythmias or cardiac arrest nearly 2-fold. However, atypical antipsychotics are not associated with an increased risk of hospitalization for ventricular arrhythmias or cardiac arrest. The use of atypical antipsychotics increased since they were first discovered and now are the mainstay of treatment, but with their broad use, heart effects have been documented, such as prolonged QT interval. Clozapine has been linked to severe cardiac problems, and risperidone has been linked to an increased risk of ventricular arrhythmias and cardiac arrest. We present a case of a patient with bipolar disorder who presented with symptomatic bradycardia secondary to aripiprazole.<\/ns3:p>","DOI":"10.12688\/f1000research.126979.1","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T07:00:08Z","timestamp":1667199608000},"page":"1233","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case Report: A rare case of symptomatic bradycardia secondary to aripiprazole in a patient with bipolar disorder type I"],"prefix":"10.12688","volume":"11","author":[{"given":"Mailing","family":"Flores Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3808-0803","authenticated-orcid":false,"given":"Nehemias","family":"Guevara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlon","family":"Argueta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yomary","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adler","family":"Vitaly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim","family":"Baghdadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2560","published-online":{"date-parts":[[2022,10,31]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e001568","DOI":"10.1161\/JAHA.114.001568","article-title":"Antipsychotic drugs and the risk of ventricular arrhythmia and\/or sudden cardiac death: a nation-wide case-crossover study.","volume":"4","author":"C Wu","year":"2015 Feb 23","journal-title":"J. Am. Heart Assoc."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"246-254","DOI":"10.9740\/mhc.2017.11.246","article-title":"Management of serious cardiac adverse effects of antipsychotic medications.","volume":"7","author":"S Stoner","year":"2017 Nov","journal-title":"Ment Health Clin."},{"key":"ref3","article-title":"Atypical antipsychotics, schizophrenia, and cardiovascular risk: What family physicians need to know.","year":"cited 2022 Sep 21","journal-title":"British Columbia Med. J."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"150-151","DOI":"10.12788\/jfp.0170","article-title":"23-year-old woman \u2022 syncopal episode \u2022 sinus bradycardia \u2022 history of bipolar disorder \u2022 Dx?","volume":"70","author":"K Fletke","year":"2021 Apr","journal-title":"J. Fam. Pract."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"681-690","DOI":"10.1001\/archpsyc.60.7.681","article-title":"Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.","volume":"60","author":"S Potkin","year":"2003 Jul","journal-title":"Arch. Gen. Psychiatry."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1400-1411","DOI":"10.1038\/sj.npp.1300203","article-title":"Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology.","volume":"28","author":"D Shapiro","year":"2003 Aug","journal-title":"Neuropsychopharmacology."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1048-1056","DOI":"10.4088\/JCP.v64n0910","article-title":"Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study.","volume":"64","author":"T Pigott","year":"2003 Sep","journal-title":"J. Clin. Psychiatry."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"760-763","DOI":"10.1345\/aph.1M621","article-title":"Symptomatic bradycardia with oral aripiprazole and oral ziprasidone.","volume":"44","author":"B Snarr","year":"2010 Apr","journal-title":"Ann. Pharmacother."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"745-751","DOI":"10.1093\/eurheartj\/ehr368","article-title":"Psychotropic medications and the risk of sudden cardiac death during an acute coronary event.","volume":"33","author":"J Honkola","year":"2012 Mar 1","journal-title":"Eur. Heart J."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"225-235","DOI":"10.1056\/NEJMoa0806994","article-title":"Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death.","volume":"360","author":"W Ray","year":"2009 Jan 15","journal-title":"N. Engl. J. Med."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e001568","DOI":"10.1161\/JAHA.114.001568","article-title":"Antipsychotic Drugs and the Risk of Ventricular Arrhythmia and\/or Sudden Cardiac Death: A Nation-wide Case-Crossover Study.","volume":"4","author":"C Wu","year":"2015 Feb 23","journal-title":"J. Am. Heart. Assoc. Cardiovasc. Cerebrovasc. Dis."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"213-223","DOI":"10.4088\/JCP.v68n0206","article-title":"Aripiprazole for Treatment-Resistant Schizophrenia: Results of a Multicenter, Randomized, Double-Blind, Comparison Study Versus Perphenazine.","volume":"68","author":"J Kane","year":"2007 Feb 1","journal-title":"J. Clin. Psychiatry."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"325-337","DOI":"10.1017\/S1461145703003651","article-title":"Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia.","volume":"6","author":"S Kasper","year":"2003 Dec 1","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"123-136","DOI":"10.1016\/S0920-9964(03)00050-1","article-title":"Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials.","volume":"61","author":"S Marder","year":"2003 Jun","journal-title":"Schizophr. Res."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"399-401","DOI":"10.2190\/U99G-XDML-0GRG-BYE0","article-title":"Severe cardiovascular side effects of olanzapine in an elderly patient: case report.","volume":"33","author":"T Lee","year":"2003","journal-title":"Int. J. Psychiatry Med."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"259-261","DOI":"10.1055\/s-2001-18033","article-title":"Asymptomatic bradycardia associated with amisulpride.","volume":"34","author":"F Pedrosa Gil","year":"2001 Nov","journal-title":"Pharmacopsychiatry."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2243-2243","DOI":"10.1176\/appi.ajp.160.12.2243","article-title":"Symptomatic Bradyarrhythmia Secondary to Risperidone.","volume":"160","author":"R Goyal","year":"2003 Dec","journal-title":"Am. J. Psychiatry."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41398-020-01119-3","article-title":"Towards in vivo imaging of functionally active 5-HT1A receptors in schizophrenia: concepts and challenges.","volume":"11","author":"O Razakarivony","year":"2021 Jan 7","journal-title":"Transl. Psychiatry."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"528-538","DOI":"10.1007\/s003950170003","article-title":"Presence, distribution and physiological function of adrenergic and muscarinic receptor subtypes in the human heart.","volume":"96","author":"O Brodde","year":"2001 Nov","journal-title":"Basic Res. Cardiol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"335-341","DOI":"10.1038\/aps.2011.201","article-title":"\u03b2-Adrenergic receptor subtype signaling in heart: from bench to bedside.","volume":"33","author":"A Woo","year":"2012 Mar","journal-title":"Acta Pharmacol. Sin."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"681-690","DOI":"10.1001\/archpsyc.60.7.681","article-title":"Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.","volume":"60","author":"S Potkin","year":"2003 Jul","journal-title":"Arch. Gen. Psychiatry."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"239-245","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions.","volume":"30","author":"C Naranjo","year":"1981 Aug","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref23","first-page":"180-185","article-title":"Efficacy and adverse effects of clozapine in four elderly psychotic patients.","volume":"56","author":"J Pitner","year":"1995 May","journal-title":"J. Clin. Psychiatry."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/11-1233\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/11-1233\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/11-1233\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T08:00:20Z","timestamp":1706256020000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/11-1233\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,31]]},"references-count":23,"URL":"https:\/\/doi.org\/10.12688\/f1000research.126979.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.139439.r154570","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.139439.r227261","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.139439.r227264","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.139439.r227264","asserted-by":"object"},{"id-type":"doi","id":"10.5256\/f1000research.139439.r227261","asserted-by":"object"},{"id-type":"doi","id":"10.5256\/f1000research.139439.r154570","asserted-by":"object"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,31]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/11-1233\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.139439.r154570, Juan Manuel Mu\u00f1oz Moreno, Department of Cardiology, Hospital Nacional Edgardo Rebagliati Martins, Lima, 06 Dec 2022, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/11-1233\/v1#referee-response-154570","order":0,"name":"referee-response-154570","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.139439.r227264, Liliang Li, School of Basic Medical Sciences, Fudan University, Shanghai, 18 Dec 2023, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/11-1233\/v1#referee-response-227264","order":1,"name":"referee-response-227264","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.139439.r227261, Barun Kumar, Department of Cardiology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, 26 Jan 2024, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/11-1233\/v1#referee-response-227261","order":2,"name":"referee-response-227261","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"The author(s) declared that no grants were involved in supporting this work","order":3,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}